Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 31;19(1):2187591.
doi: 10.1080/21645515.2023.2187591. Epub 2023 Mar 21.

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report

Affiliations
Case Reports

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report

Pati Aji Achdiat et al. Hum Vaccin Immunother. .

Abstract

Anogenital Warts (AGWs) are benign proliferations caused by Human Papillomavirus (HPV) infection on the genital or anal areas. Various therapeutic options are available for the treatment of AGWs but there is no best or ideal therapy, and the recurrence of AGWs is significantly high. A promising new therapy that is currently being evaluated is immunotherapy with the intralesional Bacillus Calmette-Guérin (BCG) vaccine. Two cases of a 23-year-old woman and a 41-year-old man were presented with manifestations of condyloma acuminata type AGWs. The patients were immunocompetent and received single dose intralesional BCG vaccine on the largest lesion. Clinical improvements of AGWs lesions were noted starting on the 14th day after receiving therapy by the disappearance of some lesions with no recurrence and side effects. Intralesional BCG vaccine activates the immune system, treats other AGWs lesions that do not receive an intralesional injection, and also prevents recurrence. Although the intralesional BCG vaccine is effective for treating AGWs, further evaluation is still needed for its recurrence.

Keywords: Anogenital warts; Bacillus Calmette-Guérin; immunotherapy.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
(a) Clinical manifestation of anogenital wart on vulva area before intralesional BCG injection; (b) some of the warty lesion demonstrate complete clearing one month after injection.
Figure 2.
Figure 2.
(a) Clinical manifestation of anogenital warts on penis shaft before intralesional BCG injection; (b) some of the warty lesion demonstrate complete clearing within 1 month.

References

    1. Suligoi B, Vittori G, Salfa MC, Timelli L, Corsini D, Fattorini G, Mariani, L.. Prevalence and incidence of ecternal genital warts in a sample of Italian general female population. BMC Infect Dis. 2017;17(1):1–5. doi:10.1186/s12879-017-2202-6. - DOI - PMC - PubMed
    1. Centers for Disease Control and Preventions . Sexually transmitted diseases treatment guidelines. CDC. 2015;64:84–90.
    1. Kosen S, Andrijono A, Ocviyanti S, Indriatmi W.. The cost-effectiveness of quadrivalent human papillomavirus vaccination in Indonesia. Asian Pac J Cancer Prev. 2011;18:2011–7. - PMC - PubMed
    1. Mones H. Treatment of noncervical condyloma acuminata. In: Pfenninger J, Fowler G, editors. Pfenninger and flower’s procedures for primary care. 3rd ed. New York: Elsevier; 2010. p. 1055–1064
    1. Sinha S, Relhan V, Garg VK. Immunomodulators in warts: unexplored or ineffective? Indian J Dermatol. 2015;60(2):118–29. doi:10.4103/0019-5154.152502. - DOI - PMC - PubMed

Publication types